Childhood height and birth weight in relation to future prostate cancer risk: A cohort study based on the Copenhagen School Health Records Register

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 12, 2013, Pages 2232-2240

  Cook, Michael B ^a   Gamborg, Michael ^b   Aarestrup, Julie ^b   Sørensen, Thorkild I A ^b,c   Baker, Jennifer L ^b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b The Capital Region   (Denmark)

^c Capital Region   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BIRTH WEIGHT; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHILD; CHILD DEVELOPMENT; CHILDHOOD; COHORT ANALYSIS; FOLLOW UP; HEIGHT; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REGISTER; RISK ASSESSMENT; SCHOOL CHILD; SCHOOL HEALTH SERVICE;

ADOLESCENT; BIRTH WEIGHT; BODY HEIGHT; CHILD; COHORT STUDIES; DENMARK; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; REGISTRIES; RISK FACTORS; SCHOOL HEALTH SERVICES;

EID: 84890050671     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0712     Document Type: Article

References (72)

1. Cheng I, Witte JS, McClure LA, Shema SJ, Cockburn MG, John EM, et al. Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California. Cancer Causes Control 2009;20:1431-40.
2. Hemminki K. Familial risk and familial survival in prostate cancer. World J Urol 2012;30:143-8.
3. McCracken M, Olsen M, Chen MS Jr, Jemal A, Thun M, Cokkinides V, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 2007;57:190-205.
4. Eeles RA, Olama AAA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013;45:385-91.
5. Swyer GIM. Post-natal growth changes in the human prostate. J Anat 1944;78:130-45.
6. Wilson JD. The critical role of androgens in prostate development. Endocrinol Metab Clin North Am 2011;40:577-90.
7. Timms BG. Prostate development: a historical perspective. Differentiation 2008;76:565-77.
8. Timms BG, Mohs TJ, Didio LJ. Ductal budding and branching patterns in the developing prostate. J Urol 1994;151:1427-32.
9. Sutcliffe S, Colditz GA. Prostate cancer: is it time to expand the research focus to early-life exposures? Nat Rev Cancer 2013;13: 208-518.
10. Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009;101:1325-9.
11. Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002;94:981-90.
12. Stephenson RA. Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database. Urol Clin North Am 2002;29:173-81.
13. Carpenter WR, Howard DL, Taylor YJ, Ross LE, Wobker SE, Godley PA. Racial differences in PSA screening interval and stage at diagnosis. Cancer Causes Control 2010;21:1071-80.
14. Jani AB, Vaida F, Hanks G, Asbell S, Sartor O, Moul JW, et al. Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era. Int J Cancer 2001;96:363-71.
15. Haas GP, Delongchamps N, Brawley OW, Wang CY, de la Roza G. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol 2008;15:3866-71.
16. Franks LM. Latent carcinoma of the prostate. J Pathol Bacteriol 1954;68:603-16.
17. Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993;150:379-85.
18. Zlotta AR, Egawa S, Pushkar D, Govorov A, Kimura T, Kido M, et al. Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. J Natl Cancer Inst 2013;105: 1050-8.
19. Whitley E, Gunnell D, Davey Smith G, Holly JM, Martin RM. Childhood circumstances and anthropometry: the Boyd Orr cohort. Ann Hum Biol 2008;35:518-34.
20. Emerging Risk Factors C. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol 2012;41:1419-33.
21. Zuccolo L, Harris R, Gunnell D, Oliver S, Lane JA, Davis M, et al. Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17: 2325-36.
22. Whitley E, Martin RM, Davey Smith G, Holly JM, Gunnell D. Childhood stature and adult cancer risk: the Boyd Orr cohort. Cancer Causes Control 2009;20:243-51.
23. Boland LL, Mink PJ, Bushhouse SA, Folsom AR. Weight and length at birth and risk of early-onset prostate cancer (United States). Cancer Causes Control 2003;14:335-8.
24. Cnattingius S, Lundberg F, Sandin S, Gronberg H, Iliadou A. Birth characteristics and risk of prostate cancer: the contribution of genetic factors. Cancer Epidemiol Biomarkers Prev 2009;18: 2422-6.
25. Ekbom A, Wuu J, Adami HO, Lu CM, Lagiou P, Trichopoulos D, et al. Duration of gestation and prostate cancer risk in offspring. Cancer Epidemiol Biomarkers Prev 2000;9:221-3.
26. Nilsen TI, Romundstad PR, Troisi R, Vatten LJ. Birth size and subsequent risk for prostate cancer: a prospective population-based study in Norway. Int J Cancer 2005;113:1002-4.
27. Platz EA, Giovannucci E, Rimm EB, Curhan GC, Spiegelman D, Colditz GA, et al. Retrospective analysis of birth weight and prostate cancer in the Health Professionals Follow-up Study. Am J Epidemiol 1998;147: 1140-4.
28. Ekbom A, Hsieh CC, Lipworth L, Wolk A, Ponten J, Adami HO, et al. Perinatal characteristics in relation to incidence of and mortality from prostate cancer. BMJ 1996;313:337-41.
29. Eriksson M, Wedel H, Wallander MA, Krakau I, Hugosson J, Carlsson S, et al. The impact of birth weight on prostate cancer incidence and mortality in a population-based study ofmen born in 1913 and followed up from 50 to 85 years of age. Prostate 2007;67:1247-54.
30. Ferguson P, Mohr L, Hoel D, Lipsitz S, Lackland D. Possible relationship between birth weight and cancer incidence among young adults. Ann Epidemiol 2000;10:471.
31. Ahlgren M, Wohlfahrt J, Olsen LW, Sørensen TIA, Melbye M. Birth weight and risk of cancer. Cancer 2007;110:412-9.
32. Baker JL, Olsen LW, Andersen I, Pearson S, Hansen B, Sørensen TIA. Cohort profile: the Copenhagen School Health Records Register. Int J Epidemiol 2009;38:656-62.
33. Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011;39:22-5.
34. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011;39:42-5.
35. World Health Organization. International statistical classification of diseases and related health problems. 10th revision, 2010 ed. Geneva, Switzerland: World Health Organization; 2011. Available from: http://www.who.int.
36. Batty GD, Shipley MJ, Gunnell D, Huxley R, Kivimaki M, Woodward M, et al. Height, wealth, and health: an overview with new data from three longitudinal studies. Econ Hum Biol 2009;7:137-52.
37. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990;44:45-60.
38. Rugholm S, Baker JL, Olsen LW, Schack-Nielsen L, Bua J, Sørensen TIA. Stability of the association between birth weight and childhood overweight during the development of the obesity epidemic. Obes Res 2005;13:2187-94.
39. Mukai TO, Bro F, Pedersen KV, Vedsted P. [Use of prostate-specific antigen testing]. Ugeskr Laeger 2010;172:696-700.
40. Gunnell D, Davey Smith G, McConnachie A, Greenwood R, Upton M, Frankel S. Separating in utero and postnatal influences on later disease. Lancet 1999;354:1526-7.
41. Bogin B, Baker J. Low birth weight does not predict the ontogeny of relative leg length of infants and children: an allometric analysis of the NHANES III sample. Am J Phys Anthropol 2012;148:487-94.
42. Gigante DP, Nazmi A, Lima RC, Barros FC, Victora CG. Epidemiology of early and late growth in height, leg, and trunk length: findings from a birth cohort of Brazilian males. Eur J Clin Nutr 2009;63:375-81.
43. Eide MG, Oyen N, Skjoerven R, Nilsen ST, Bjerkedal T, Tell GS. Size at birth and gestational age as predictors of adult height and weight. Epidemiology 2005;16:175-81.
44. Wadsworth ME, Hardy RJ, Paul AA, Marshall SF, Cole TJ. Leg and trunk length at 43 years in relation to childhood health, diet and family circumstances; evidence from the 1946 national birth cohort. Int J Epidemiol 2002;31:383-90.
45. Gunnell D, May M, Ben-Shlomo Y, Yarnell J, Davey Smith G. Height, leg length, and cancer: the Caerphilly Study. Nutr Cancer 2003;47:34-9.
46. Okasha M, Gunnell D, Holly J, Davey Smith G. Childhood growth and adult cancer. Best Pract Res Clin Endocrinol Metab 2002;16:225-41.
47. Miller FJ, Billewicz WZ, Thomson AM. Growth from birth to adult life of 442 Newcastle upon Tyne children. Br J Prev Soc Med 1972;26: 224-30.
48. Olivier G, Bressac F, Tissier H. Correlations between birth length and adult stature. Hum Biol 1978;50:69-72.
49. Loesch DZ, Huggins RM, Stokes KM. Relationship of birth weight and length with growth in height and body diameters from 5 years of age to maturity. Am J Hum Biol 1999;11:772-8.
50. Gerver WJ, De Bruin R. Relationship between height, sitting height and subischial leg length in Dutch children: presentation of normal values. Acta Paediatr 1995;84:532-5.
51. Leitch I. Growth and health. Br J Nutr 1951;5:142-51.
52. Buckler JMH. Growth at Adolescence. In:Kelnar CJH, Savage MO, Saenger P, Cowell CT, editors. Growth disorders. 2nd ed. Florida, USA: CRC Press; 2007. p. 150-64.
53. Scammon RE. The measurement of the body in childhood. In:Harris JA, Jackson CM, Paterson DG, Scammon RE, editors. The measurement of man. Minneapolis, MN: University of Minnesota Press; 1930. p. 173-215.
54. Chyou PH, Nomura AM, Stemmermann GN. A prospective study of weight, body mass index and other anthropometric measurements in relation to site-specific cancers. Int J Cancer 1994;57:313-7.
55. Karlberg J, Jalil F, Lam B, Low L, Yeung CY. Linear growth retardation in relation to the three phases of growth. Eur J Clin Nutr 1994;48 Suppl 1:S25-43.
56. Neuhouser ML, Platz EA, Till C, Tangen CM, Goodman PJ, Kristal A, et al. Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial. Cancer Prev Res 2013;6:91-9.
57. Price AJ, Allen NE, Appleby PN, Crowe FL, Travis RC, Tipper SJ, et al. Insulin-like growth factor-I concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2012;21:1531-41.
58. Tsilidis KK, Travis RC, Appleby PN, Allen NE, Lindstrom S, Albanes D, et al. Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Int J Cancer 2013;133: 495-504.
59. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995;80:2534-42.
60. Brandstedt J, Almquist M, Manjer J, Malm J. Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study. Cancer Causes Control 2012;23:1377-85.
61. Park SY, Wilkens LR, Morris JS, Henderson BE, Kolonel LN. Serum zinc and prostate cancer risk in a nested case-control study: the multiethnic cohort. Prostate 2013;73:261-6.
62. Roswall N, Larsen SB, Friis S, Outzen M, Olsen A, Christensen J, et al. Micronutrient intake and risk of prostate cancer in a cohort of middleaged, Danish men. Cancer Causes Control 2013;24:1129-35.
63. Albanes D. Energy balance, body size, and cancer. Crit Rev Oncol Hematol 1990;10:283-303.
64. Fuemmeler BF, Pendzich MK, Tercyak KP. Weight, dietary behavior, and physical activity in childhood and adolescence: implications for adult cancer risk. Obesity Facts 2009;2:179-86.
65. Dirx MJ, van den Brandt PA, Goldbohm RA, Lumey LH. Energy restriction in childhood and adolescence and risk of prostate cancer: results from the Netherlands Cohort Study. Am J Epidemiol 2001;154: 530-7.
66. Ulijaszek SJ. The international growth standard for children and adolescents project: environmental influences on preadolescent and adolescent growth in weight and height. Food Nutr Bull 2006;27:S279-94.
67. Paternoster L, Howe LD, Tilling K, Weedon MN, Freathy RM, Frayling TM, et al. Adult height variants affect birth length and growth rate in children. Hum Mol Genet 2011;20:4069-75.
68. Diamandis EP, Yu H. Does prostate cancer start at puberty? J Clin Lab Anal 1996;10:468-9.
69. Barker DJ, Osmond C, Thornburg KL, Kajantie E, Eriksson JG. A possible link between the pubertal growth of girls and prostate cancer in their sons. Am J Hum Biol 2012;24:406-10.
70. Albanes D, Winick M. Are cell number and cell proliferation risk factors for cancer? J Natl Cancer Inst 1988;80:772-4.
71. Sheikhazadi A, Sadr SS, Ghadyani MH, Taheri SK, Manouchehri AA, Nazparvar B, et al. Study of the normal internal organ weights in Tehran's population. J Forensic Leg Med 2010;17:78-83.
72. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966;50:125-8.